Progyny (PGNY) PT Raised to $31 at Citizens on Post-Q1 EBITDA Estimate Raise
Tweet Send to a Friend
Citizens analyst Constantine Davides raised the price target on Progyny (NASDAQ: PGNY) to $31.00 (from $30.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
